Zooming in on Cancer Suspects - Insights

Genetic testing is like security-camera video footage of a break-in, providing essential clues to identify a culprit. In certain cancers, the "culprit" might be a rearrangement in a person's DNA, which genomic testing can capture. Mayo...

Testing Archives - Page 17 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Direct Ethanol Biomarker Testing: PETH - Insights

Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' new direct biomarker test for alcohol consumption. PETH is a blood test with a window of detection of about two to four weeks — compared with five days for urine-based screening for...

Staphylococcus species assay [Test in Focus] - Insights

Audrey Schuetz, M.D., discusses Mayo Clinic Laboratories' PCR assay that identifies two recently described staphylococcus species. The assay is unique in its ability to distinguish the new organisms from Staphylococcus aureus, providing...

SARS-CoV-2, Influenza A and B, and Respiratory Syncytial Virus (RSV) - Insights

Joseph Yao, M.D., explains how Mayo Clinic Laboratories’ SARS four-target test for viral respiratory disease can enhance patient care. The test detects RNA from SARS-CoV-2, influenza A, influenza B and respiratory syncytial virus, or RSV....

Testing Archives - Page 9 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 10 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 18 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Testing Archives - Page 11 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Rapid response: COVID-19, monkeypox, and whatever comes next - Insights

Mayo Clinic Laboratories' rapid response to public health threats has been honed during outbreaks of viruses like 2009’s H1N1 influenza, Zika, Ebola and, most recently, COVID-19. Before COVID-19, laboratory staff were already experts in...